Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry.

[1]  M. Spitz,et al.  Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. , 1997, Carcinogenesis.

[2]  J. Freudenheim,et al.  Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk. , 1998, Cancer research.

[3]  J. Freudenheim,et al.  Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. , 1996, JAMA.

[4]  Bert Vogelstein,et al.  Gatekeepers and caretakers , 1997, Nature.

[5]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[6]  A. Warren,et al.  Molecular Epidemiology: Carcinogen-DNA Adducts and Genetic Susceptibility , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[7]  A. Dipple,et al.  DNA adducts of chemical carcinogens. , 1995, Carcinogenesis.

[8]  J. Vogel.  Rapid Production of Graphite Without Contamination for Biomedical AMS , 1992, Radiocarbon.

[9]  L. Harries,et al.  Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. , 1997, Carcinogenesis.

[10]  F P Perera,et al.  Environment and cancer: who are susceptible? , 1997, Science.

[11]  E. Bowman,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. , 1993, Cancer research.

[12]  Donghui Li,et al.  Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. , 1996, Cancer research.

[13]  M. Poirier.  DNA adducts as exposure biomarkers and indicators of cancer risk. , 1997, Environmental health perspectives.

[14]  E. Bowman,et al.  Standardization of the 32P-postlabeling assay for polycyclic aromatic hydrocarbon-DNA adducts. , 1993, Mutagenesis.

[15]  J. Manson,et al.  Glutathione S-transferase class mu deletion polymorphism and breast cancer: results from prevalent versus incident cases. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  Mark L. Roberts,et al.  LLNL/UC AMS facility and research program , 1990 .

[17]  R. C. Garner,et al.  Correlation of DNA adduct levels in human lung with cigarette smoking , 1988, Nature.

[18]  H. Bartsch,et al.  The role of individual susceptibility in cancer burden related to environmental exposure. , 1996, Environmental health perspectives.

[19]  M. Stuiver,et al.  Discussion: Reporting of 14 C Data , 1977 .

[20]  R. Moschel,et al.  Aralkylation of 2'-deoxyguanosine: medium effects on sites of reaction with 7-(bromomethyl)benz[a]anthracene. , 1990, Chemical research in toxicology.

[21]  K. Hemminki,et al.  DNA and protein adducts. , 1995, Toxicology.

[22]  G. Wogan.  Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. , 1992, Environmental health perspectives.

[23]  Steven R. Tannenbaum,et al.  Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens , 1994, Nature.

[24]  P. Pisani,et al.  Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology. , 1997, IARC scientific publications.

[25]  A. Dipple,et al.  Methodologies for measuring carcinogen adducts in humans. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  K. Turteltaub,et al.  Accelerator mass spectrometry. , 1995, Analytical chemistry.

[27]  D. Bell,et al.  Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. , 1995, Cancer research.

[28]  A. Weston,et al.  Human DNA adduct measurements: state of the art. , 1996, Environmental health perspectives.

[29]  J. Groopman,et al.  Molecular biomarkers for aflatoxins and their application to human cancer prevention. , 1994, Cancer research.

[30]  C. Harris,et al.  Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. , 1989, Carcinogenesis.

[31]  J. M. Roman,et al.  DNA adducts from carcinogenic and noncarcinogenic enantiomers of benzo[a]pyrene dihydrodiol epoxide. , 1989, Chemical research in toxicology.

[32]  K. A. Connors,et al.  N-Methylimidazole-catalyzed acetylation of hydroxy compounds prior to gas chromatographic separation and determination , 1979 .

[33]  J D Tucker,et al.  New molecular endpoints and methods for routine toxicity testing. , 1995, Fundamental and applied toxicology : official journal of the Society of Toxicology.